KDEV INVESTMENTS
KDEV INVESTMENTS
Status:
Active
Investments List
Date | Company | Article | Money raised |
---|---|---|---|
2017-02-20 | Modus Therapeutics | KDev Investments investment in Venture Round - Modus Therapeutics | 32 M SEK |
More informations about "KDev Investments"
KDev Investments AB - Företagsinformation - allabolag.se
KDev Investments AB,556880-1608 - På allabolag.se hittar du , bokslut, nyckeltal, koncern, koncernträd, styrelse, Status, adress mm för KDev Investments ABSee details»
Karolinska Development as an investment
The returns from KDev Investmentsโ holdings, including Rosetta Capitalโs investments in portfolio companies, will be distributed in accordance with a so-called waterfall structure, as illustrated โฆSee details»
KDev Investments - Crunchbase Investor Profile & Investments
Feb 20, 2017 Modus Therapeutics raised SEK32,000,000 / Series Unknown from KDev Investments and 3 other investors . Discover more funding rounds . Details. Edit Details โฆSee details»
Kdev Investments AB Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Kdev Investments AB of Solna, Stockholm. Get the latest business insights from Dun & Bradstreet.See details»
KDev Investments AB | Aktiebolag | Info & Löner - Bolagsfakta
KDev Investments AB โ Org.nummer: 556880-1608. På Bolagsfakta.se hittar du kontakt-och företagsinformation, nyckeltal, lön till VD & styrelse m.m.See details»
Karolinska - Crunchbase Investor Profile & Investments
Return on investment can be achieved; and COMMERCIALIZE the innovations through the sale of companies or out-licensing of products. Karolinska Development has developed a well-structured selection process to identify the โฆSee details»
Karolinska Development som investering
Avkastningen från KDev Investments innehav, inklusive Rosetta Capitals investeringar i portföljbolagen, kommer fördelas enligt en så kallad vattenfallsstruktur, vilken illustreras i โฆSee details»
KDev Investments AB i Solna โ Info - Ratsit
Mar 20, 2025 KDev Investments AB - Org.nummer: 5568801608. Fördelningen i styrelsen är 100,0 % män (2), 0,0 % kvinnor (0) . Ansvarig är Viktor Drvota 59 år. På Ratsit hittar du โฆSee details»
KDev Investments - Investments, Portfolio & Company Exits
KDev Investments has invested in Modus Therapeutics on Feb 20, 2017. This investment - Venture Round ... obfuscated. obfuscated. How many investments has this organization made โฆSee details»
Karolinska Development โ Wikipedia
KDev Investments AB (med Rosetta Capital) Karolinska Development AB är ett svenskt investmentföretag för läkemedels- och biotekniska företag. Det grundades 2003 för att โฆSee details»
KDev Investments AB - Drug pipelines, Patents, Clinical trials
Explore KDev Investments AB with its drug pipeline, therapeutic area, technology platform, 5 news.See details»
Karolinska Development AB, KDEV:STO profile - FT.com
Karolinska Development AB is a Sweden-based investment company. The Company provides capital to biotechnology firms, as well as develops and commercializes biotechnological โฆSee details»
Karolinska Development AB (publ) | Globenewswire
Oct 12, 2024 Karolinska Development AB (Nasdaq Stockholm: KDEV) is a Nordic life sciences investment company. The company focuses on identifying breakthrough medical innovations โฆSee details»
KDev Investments AB - Koncernstruktur - allabolag.se
KDev Investments AB,556880-1608 - På allabolag.se hittar du , bokslut, nyckeltal, koncern, koncernträd, styrelse, Status. INFORMATION. På torsdag den 12 september är vår โฆSee details»
Company Karolinska Development AB - MarketScreener.com
Nov 27, 2017 KDev Investments AB engages in research, sales, and development in the fields of medicine, biotechnology, pharmaceuticals, and medical technology. It also owns and โฆSee details»
KDEV | Karolinska Development AB Stock Overview (Sweden
Its portfolio investments include Umecrine Cognition, Forendo Pharma, OssDsign, Modus Therapeutics, Dilafor, Aprea Therapeutics, Lipidor, Promimic, and Asarina Pharma. The โฆSee details»
Karolinska Development divests 4,6 million shares in
Oct 12, 2024 Karolinska Development AB (Nasdaq Stockholm: KDEV) divests 4,6 million shares in the portfolio company OssDsign and thereby strengthens the investment companyโs liquidity.See details»
KDev Investments AB Stock Data, Filings, Earnings, News
Get the latest news, data and filings for KDev Investments AB, with free alerts. Includes transcripts, social sentiment, and more.See details»
KDev Investments AB - Bolagshändelser - allabolag.se
KDev Investments AB,556880-1608 - På allabolag.se hittar du , bokslut, nyckeltal, koncern, koncernträd, styrelse, StatusBolagshändelser för KDev Investments ABSee details»
Karolinska Development (KDEV) Investor Relations Material
Nov 15, 2024 Access Karolinska Development (KDEV) Investor Relations material, such as Live Earnings Calls, Transcripts, Slides, Reports, and Estimates using Quartr ... Karolinska โฆSee details»